[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][=C][C][=C][Branch2][#Branch1][#C][C@@H1][C@@H1][C@H1][C][=C][Branch2][=Branch1][P][C][=Branch2][=Branch1][N][=C][C][=Branch2][Branch1][P][=C][Ring1][=Branch1][C@@H1][Branch2][Ring1][C][N][Ring1][#Branch2][C@H1][Branch1][O][C@H1][Branch1][Ring2][C][Ring1][S][N][Ring1][#C][C][O][C][O][C][=Branch1][C][=O][C@@][Branch1][=Branch1][C][S][Ring2][Ring1][=Branch1][C][=C][Branch1][=Branch1][C][C][N][Ring1][Branch2][C][=C][Branch1][Ring2][N][Ring1][Branch2][C][=C][C][=Branch1][Ring2][=C][Ring1][#Branch1][O][C][O][C][O][Ring2][Ring2][Ring1][C][O][C][=Branch1][C][=O][C][C][=Branch1][#Branch1][=C][Ring2][Branch1][Ring2][O][C][O]"}, {"from": "gpt", "value": "The molecule is a synthetic tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogue with potential antineoplastic activity. Lurbinectedin covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death."}]